Proteomic Analysis of Human Hepatocellular Carcinoma Associated With Portal Vein Thrombosis
N/A
18 Years
75 Years
18 Years
75 Years
Open (Enrolling)
Both
Carcinoma, Hepatocellular
Both
Carcinoma, Hepatocellular
Trial Information
Proteomic Analysis of Human Hepatocellular Carcinoma Associated With Portal Vein Thrombosis
Inclusion Criteria:
Arm A: Hepatocellular carcinoma with vessel invasion:
- hepatocellular carcionoma, pathologic diagnosed.
- image documented vessel invasion, including portal vein thrombosis
- eligible for surgical intervension.
Arm B: hepatocellular carcinoma without vessel invasion:
- hepatocellular carcinoma, pathologic diagnosed or clinical diagnosed according to
EASL criteria.
- no vessel invasion on image.
Arm C: Healthy hepatitis carrier:
- patients age >18 years old with hepatitis B or C
- normal liver function.
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Outcome Measure:
Recurrence
Outcome Description:
Evidence of clinically definite vascular invasion of hepatocellular carcinoma. Confirmed by operation. Compare the proteomic expression of tumor, non-tumor ans tumor tissue in vascular part.
Outcome Time Frame:
one year
Safety Issue:
No
Authority:
Taiwan: Institutional Review Board
Study ID:
97068
NCT ID:
NCT01177631
Start Date:
February 2009
Completion Date:
January 2010
Related Keywords:
- Carcinoma, Hepatocellular
- Carcinoma, hepatocellular
- Portal vein
- Proteomics
- Carcinoma
- Carcinoma, Hepatocellular
Name | Location |
|---|
